Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Neoplasie
25. September 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 8166
Artikel 1 - 20 / 163306
Meta-analysis of the changes in clinical features and characteristics of lung cancer under bronchoscopy.
Am J Clin Exp Immunol
Wang L, Zhou J, Hu R.
PMID: 42787643 [PubMed]
The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials.
Front Immunol
Huang Y, Ma J, Bi J, Pi G, Li Y, Peng Y, Xiao C, Tuo X, Han G.
PMID: 42787504 [PubMed - indexed for MEDLINE]
The oral-lung axis in lung cancer: microbial translocation, immune reprogramming, and clinical implications.
Front Immunol
Liu X, Ding G, Lu J, Song W, Li Y, Chen X, Cui J.
PMID: 42787422 [PubMed - indexed for MEDLINE]
The association of the advanced lung cancer inflammation index with the risk of Helicobacter pylori infection and mortality: a study of populations from two countries.
Front Cell Infect Microbiol
Hu Q, Zhu H, Wei Q, Shen Q, Xiong M, Huang S.
PMID: 42787355 [PubMed - indexed for MEDLINE]
Dynamic serum tumor-marker and immune-inflammatory biomarker changes for risk stratification of immune checkpoint inhibitor-associated myasthenia gravis in non-small cell lung cancer.
Front Immunol
Cui P, Lin X, Luo W, Zhang S, Zhang S, Xu S, Lai J, Xiong Y, Chen D, Huang B, Xu Z.
PMID: 42787263 [PubMed - indexed for MEDLINE]
Efficacy and safety of risk-adapted modified stereotactic body radiotherapy for lung tumors: a single-institution retrospective study.
J Radiat Res
Oka A, Yamashita H, Miki Y, Sawayanagi S, Nozawa Y, Sugahara D, Hayashi T, Suzuki T, Katano A.
PMID: 42786599 [PubMed - as supplied by publisher]
Longitudinal spatial multi-omics delineates tumor microenvironment remodeling across sequential EGFR-TKIs in EGFR-mutant NSCLC.
J Transl Med
Song X, Pan C, Li Z, Zhou X, Xiong A, Zhao Z, Luo H, Zhou C.
PMID: 42786513 [PubMed - indexed for MEDLINE]
AdvanTIG-105: a phase I/Ib dose-expansion study of ociperlimab plus tislelizumab with or without chemotherapy in metastatic non-small cell lung cancer and extensive-stage small cell lung cancer.
J Immunother Cancer
Lu S, Yu Y, Zhang J, Wang Q, Cho EK, Zhao J, Kim SH, Lee Y, Clay TD, Yang TY, Chang GC, Yang H, Zuo Y, Liu R, Sun P, Kim HR.
PMID: 42785919 [PubMed - indexed for MEDLINE]
Patient Experiences With a Symptom Monitoring and Self-Referral Program for Specialty Palliative Care After Lung Cancer Diagnosis: Qualitative Study.
JMIR Form Res
Agne JL, Gaughan AA, Rush LJ, Eramo JL, Sinclair A, Grogan MM, Merlin JS, Stevens J, Cronin RM, Padamsee TJ, Presley CJ, McAlearney AS.
PMID: 42785736 [PubMed - indexed for MEDLINE]
Additive local radical therapy in synchronous oligometastatic non-small cell lung cancer without oncogenic drivers: a single-center retrospective cohort study.
Cancer Treat Res Commun
Aßmann MD, Aust MH, Rades D, Drömann D, Bohnet S, Franzen KF.
PMID: 42785040 [PubMed - as supplied by publisher]
Gap Between Estimated Need and Observed Uptake of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Among Patients With Lung Cancer in Indonesia.
JCO Glob Oncol
Asmara OD, Tenda ED, Radityamurti F, Indirawati NN, Wijaya IPEK, Habib H, Herikurniawan H, Yulianti M, Singh G, Kamelia T, Pitoyo CW, Rumende CM, Amin Z, Pinandari AW, Susanto YDB, Rachmadi L, Rajabto W, Rachman A, Sudoyo AW, Boerma EC, Gondhowiardjo SA, van Geffen WH.
PMID: 42784784 [PubMed - indexed for MEDLINE]
LungRad-BM: Accurately Predicting Brain Metastasis in Non-small Cell Lung Cancer via a Multimodal Deep Learning Framework on (18)F-FDG PET/CT Radiomics.
IEEE J Biomed Health Inform
Yuan Z, Luo Y, Chen X, Qi N, Zhao J, Huang D, Chen K, Lin S.
PMID: 42784496 [PubMed - as supplied by publisher]
Molecular Residual Disease in Non-Small Cell Lung Cancer: Technology or Patient Outcomes?
J Pers Med
Walker PR.
PMID: 42783485 [PubMed]
Early Detection of Glottic Cancer Through Machine Learning and Acoustic Voice Analysis: A Systematic Review.
Med Sci (Basel)
Verma H, Mishra R, Nagamani B, Patro SK, Ramavat AS, Bakshi J, Khandnor P, Rani S, Chand T.
PMID: 42783454 [PubMed - indexed for MEDLINE]
Beyond Lymphovascular Invasion: Site-Dependent Patterns of Lymphatic, Venous and Perineural Involvement in Laryngo-Hypopharyngeal Carcinoma.
Med Sci (Basel)
Popa RA, Popa CG, Hînganu D, Hînganu MV, Stan CI, Tracicaru RV, Boi.
PMID: 42783400 [PubMed - indexed for MEDLINE]
Cerebral Amyloid Angiopathy-Related Inflammation Mimicking Leptomeningeal Metastasis After Resected Lung Adenocarcinoma: A Case Report Highlighting Dynamic Diagnostic Reassessment.
Curr Oncol
Shigeyama K, Dotsu Y, Yoshimura S, Hiu T, Ueki N, Futsuki R, Koga S, Honda N, Akagi K, Matsuo M, Taniguchi H, Takemoto S, Mukae H.
PMID: 42782908 [PubMed - indexed for MEDLINE]
Long-Term Cutaneous Hyperpigmentation During Adjuvant Osimertinib Therapy in a Resected Stage IIB EGFR L858R-Mutated Lung Adenocarcinoma in an Older Adult: A Rare Case Report with Two-Year Follow-Up and Literature Review.
Curr Oncol
Alves MS, Ventura Barros JPQ, Maia DCC, Costa IS, Campos Junior OR, Ribeiro Junior HL.
PMID: 42782882 [PubMed - indexed for MEDLINE]
Tolerance and Efficacy of Targeted Therapies After Immunotherapy for Advanced Non-Small Cell Lung Cancers Harboring Oncogenic Alterations: The GFPC-TOXIMAD Study.
Curr Oncol
Pierret T, Auliac JB, Ricordel C, Daniel C, Nguyen J, Guisier F, Swalduz A, Curcio H, Desage AL, Bigay-Game L, Huchot E, Falchero L, Doubre H, Bylicki O, Chouaïd C, Greillier L.
PMID: 42782857 [PubMed - indexed for MEDLINE]
DNA Damage Response Alterations Stratify Response to ICI-Based Therapy in Advanced NSCLC with High PD-L1 Expression.
Curr Oncol
Hao F, Zhang L, Zhong D.
PMID: 42782855 [PubMed - indexed for MEDLINE]
Identifying Barriers and Strategies to Support a Community Navigator-Driven Approach for Lung Cancer Screening.
Curr Oncol
Reid MJ, LeLaurin JH, Ali S, Sorial C, Bylund CL, Woodard JN, Wollney EN, Goede DL, Lee JH, Nelson DS, Carter-Bawa L, Salloum RG.
PMID: 42782846 [PubMed - indexed for MEDLINE]
Artikel 1 - 20 / 163306
Seite 1 von 8166
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung